Previous Issues

Socialize

Mathews Journal of Pharmaceutical Science

Information Links

Editor Guidelines Submit Manuscript Author Guidelines Reviewer Guidelines Processing Charges Publication Ethics FAQ's Contact Us

Volume 8, Issue 3 - 2024 Volume 8, Issue 2 - 2024 Volume 8, Issue 1 - 2024 Volume 7, Issue 4 - 2023 Volume 7, Issue 3 - 2023 Volume 7, Issue 2 - 2023 Volume 7, Issue 1 - 2023 Volume 6, Issue 1 - 2022 Volume 5, Issue 1 - 2021 Volume 4, Issue 2 - 2020

Previous Issues

Volume 7, Issue 3 - 2023

Case Report

Desensitization in a Patient with Hypersensitivity to the Iodinated Contrast Medium Iopromide: A Clinical Case Report

Authors : Dadier Antonio Arroyo^1,2,*, Linda Atencio¹, Jorge Pérez Velásquez³, María Camila Coronado¹, Meribeth Henry⁴, Maria Alejandra Suarez², Daniela Katerine Rivera²
Citation : Arroyo DA, et al. (2023). Desensitization in a Patient with Hypersensitivity to the Iodinated Contrast Medium Iopromide: A Clinical Case Report. Mathews J Pharma Sci. 7(3):23.

Editorial Article

We Continue to Battle with Diseases that are Difficult to Diagnose and Cure in the 21^st Century

Author : Raúl Isea*
Citation : Isea R. (2023). We Continue to Battle with Diseases that are Difficult to Diagnose and Cure in the 21^st Century. Mathews J Pharma Sci. 7(3):22.

Research Article

Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study

Authors : Allen B Richon^1,*, Merry Ambos Richon²
Citation : Richon AB, et al. (2023). Four-Week Safety and Acceptability Study of 15% Bromelain Topical Lotion: An Open Label, Non-Comparative, Triple-Arm Study. Mathews J Pharma Sci. 7(3):21.